Greetings MAPS Members and Friends, Here is the latest news from the Multidisciplinary Association for Psychedelic Studies. There’s lots going on… MAPS grant application submitted to NIMH for …
Greetings, MAPS members and friends! As MAPS staffer Brandy Doyle is transferring her tasks to me, this is my first edition of the MAPS Email News Update. Heres the news to report this month: 1. Israeli …
Greetings, MAPS members & friends! The MAPS staff has just returned from a very productive trip to Israel, where we held a one-day conference on MDMA research and met with Ministry of Health & …
Greetings, MAPS members and friends! We have progress to report on several fronts: 1. MAPS assembles pro bono legal team for DEA lawsuit 2. Sixth patient treated in MDMA/PTSD study 3. Media flurry surrounds …
Greetings, MAPS members and friends! The longest day of winter has passed, and maybe so has the decades-long era of resistance to psychedelic research. On December 17, the FDA approved Dr. John Halpern’s …
Greetings, MAPS members and friends! Election results got ya down? Starting to get the holiday blues? Looking for something to brighten your November? Read on! We’ve got so much good news I’m …
Greetings, MAPS members and friends! It continues to be a busy and productive summer as we move forward on projects in progress and on those still in the “visionary” stage… 1. MAPS launches …
Greetings MAPS members and friends, We’ve just returned from MAPS fantastic “Body Electric” fundraiser event, which brought over 200 people to Manhattan to eat, converse, and dance through …
Greetings, MAPS members and friends! These have been very busy and productive times for the MAPS staff, as we’ve been traveling to conferences and out of the office for several weeks. In early June, …
Greetings, MAPS members and friends! We’re proud to be able to include a historic and exciting report in this month’s email newsletter. 1. MAPS’ MDMA/PTSD study fully approved!! And in …
Greetings, MAPS members and friends! We’re proud to be able to include a historic and exciting report in this month’s email newsletter. 1. MAPS’ MDMA/PTSD study fully approved!! And in …
Hello, MAPS members and friends! In today’s news from MAPS: 1. FDA replies to DEA regarding Dr. Michael Mithoefer’s Schedule I license for MDMA/PTSD study; DEA should respond soon 2. Dr. Mithoefer …